Talking Automation in Fill/Finish and Cell & Gene Therapies with James Rorke (INTERPHEX 2023)

James Rorke, vice-president, operations, Steriline North America, discusses the advantages of automation in fill/finish, particulary for low volume, high quaility products such as cell and gene therapies, for which minimizing product loss is crucial.

For more INTERPHEX 2023 video content, check this page for updates.